user

Evidence of extensive cellular immune response after SARS-CoV-2 vaccination in ocrelizumab-treated patients with multiple sclerosis

被引：0
|
作者：
Mosche Pompsch
Neslinur Fisenkci
Peter A. Horn
Markus Kraemer
Monika Lindemann
机构：
[1] Alfried Krupp Hospital,Department of Neurology
[2] University of Duisburg-Essen,Institute for Transfusion Medicine, University Hospital Essen
[3] Medical Faculty of Heinrich-Heine-University,Department of Neurology
来源：
Neurological Research and Practice | / 3卷
关键词：
Ocrelizumab; B-cell depleted patients; SARS-CoV2 vaccination; Comirnaty®; T-cell mediated response; Lack of antibody response; Multiple sclerosis; COVID-19;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Evidence of extensive cellular immune response after SARS-CoV-2 vaccination in ocrelizumab-treated patients with multiple sclerosis
    Pompsch, Mosche
    Fisenkci, Neslinur
    Horn, Peter A.
    Kraemer, Markus
    Lindemann, Monika
    NEUROLOGICAL RESEARCH AND PRACTICE, 2021, 3 (01):
  • [2] Reduced humoral immune response after mRNA vaccination correlates with breakthrough SARS-CoV-2 infection in ocrelizumab-treated multiple sclerosis patients
    Novak, Frederik
    Bajwa, Hamza
    Coia, John Eugenio
    Nilsson, Anna Christine
    Nielsen, Christian
    Holm, Dorte
    Ostergaard, Kamilla
    Hvidt, Mathilde
    Byg, Keld-Erik
    Johansen, Isik
    Mittl, Kristen
    Rowles, William
    Zamvil, Scott
    Bove, Riley
    Sabatino, Joseph
    Sejbaek, Tobias
    NEUROLOGY, 2023, 100 (17)
  • [3] Immune response in ofatumumab treated multiple sclerosis patients after SARS-CoV-2 vaccination
    Faissner, Simon
    Heitmann, Neele
    Plaza-Sirvent, Carlos
    Trendelenburg, Paulina
    Ceylan, Ulas
    Motte, Jeremias
    Bessen, Clara
    Urlaub, Doris
    Watzl, Carsten
    Overheu, Oliver
    Reinacher-Schick, Anke
    Hellwig, Kerstin
    Pfaender, Stephanie
    Schmitz, Ingo
    Gold, Ralf
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [4] Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab
    Brill, Livnat
    Rechtman, Ariel
    Zveik, Omri
    Haham, Nitzan
    Oiknine-Djian, Esther
    Wolf, Dana G.
    Levin, Netta
    Raposo, Catarina
    Vaknin-Dembinsky, Adi
    JAMA NEUROLOGY, 2021, 78 (12) : 1510 - 1514
  • [5] Humoral immune response after SARS-CoV-2 vaccination in cladribine-treated multiple sclerosis patients
    Mimpen, M.
    Kreiter, D.
    Kempkens, T.
    Knippenberg, S.
    Hupperts, R.
    Gerlach, O.
    VACCINE: X, 2024, 16
  • [6] Ocrelizumab Concentration Is a Good Predictor of SARS-CoV-2 Vaccination Response in Patients with Multiple Sclerosis
    van Kempen, Zoe L. E.
    Hogenboom, Laura
    Toorop, Alyssa A.
    Steenhuis, Maurice
    Stalman, Eileen W.
    Kummer, Laura Y. L.
    van Dam, Koos P. J.
    Bloem, Karien
    ten Brinke, Anja
    van Ham, S. Marieke
    Kuijpers, Taco W.
    Wolbink, Gerrit J.
    Loeff, Floris C.
    Wieske, Luuk
    Eftimov, Filip
    Rispens, Theo
    Strijbis, Eva M. M.
    Killestein, Joep
    ANNALS OF NEUROLOGY, 2023, 93 (01) : 103 - 108
  • [7] Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumab
    Raeuber, Saskia
    Korsen, Melanie
    Huntemann, Niklas
    Rolfes, Leoni
    Muentefering, Thomas
    Dobelmann, Vera
    Hermann, Alexander M.
    Koelsche, Tristan
    Lipinski, Karin von Wnuck
    Schroeter, Christina B.
    Nelke, Christopher
    Regner-Nelke, Liesa
    Ingwersen, Jens
    Pawlitzki, Marc
    Teegen, Bianca
    Barnett, Michael Harry
    Hartung, Hans-Peter
    Aktas, Orhan
    Albrecht, Philipp
    Levkau, Bodo
    Melzer, Nico
    Ruck, Tobias
    Meuth, Sven G.
    Kremer, David
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (09): : 978 - 985
  • [8] Diminished seroconversion following a single SARS-COV-2 vaccine in ocrelizumab-treated relapsing-remitting multiple sclerosis patients
    Georgieva, Zoya G.
    Doffinger, Rainer
    Kumararatne, Dinakantha
    Coles, Alasdair J.
    McCarthy, Claire
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (07) : 1126 - 1130
  • [9] Preliminary evidence of blunted humoral response to SARS-Cov-2 (MRNA) vaccine in multiple sclerosis patients treated with ocrelizumab
    Gallo, Antonio
    Capuano, Rocco
    Donnarumma, Giovanna
    Bisecco, Alvino
    Grimaldi, Elena
    Conte, Miriana
    D'Ambrosio, Alessandro
    Galdiero, Massimiliano
    Tedeschi, Gioacchino
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [10] Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab
    Gallo, Antonio
    Capuano, Rocco
    Donnarumma, Giovanna
    Bisecco, Alvino
    Grimaldi, Elena
    Conte, Miriana
    d'Ambrosio, Alessandro
    Coppola, Nicola
    Galdiero, Massimiliano
    Tedeschi, Gioacchino
    NEUROLOGICAL SCIENCES, 2021, 42 (09) : 3523 - 3526
12345